Journal article

CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

D Herszfeld, E Wolvetang, E Langton-Bunker, TL Chung, AA Filipczyk, S Houssami, P Jamshidi, K Koh, AL Laslett, A Michalska, L Nguyen, BE Reubinoff, I Tellis, JM Auerbach, CJ Ording, LHJ Looijenga, MF Pera



The application of human embryonic stem (hES) cells in regenerative medicine will require rigorous quality control measures to ensure the safety of hES cell-derived grafts. During propagation in vitro, hES cells can acquire cytogenetic abnormalities as well as submicroscopic genetic lesions, such as small amplifications or deletions. Many of the genetic abnormalities that arise in hES cell cultures are also implicated in human cancer development. The causes of genetic instability of hES cells in culture are poorly understood, and commonly used cytogenetic methods for detection of abnormal cells are capable only of low-throughput analysis on small numbers of cells. The identification of bioma..

View full abstract

University of Melbourne Researchers